EUS Procedures Using RIVOS™ EUS Access Device

Part of paid clinical trials in Orlando, Florida.

Sponsor
Orlando Health, Inc.
Study ID
NCT07696572
Status
Recruiting
Apply to this trial

Conditions

  • Biliary Obstruction
  • Chronic Pancreatitis
  • Pancreatic Cancer Non-resectable
  • Pancreatic Duct Obstruction
  • Pancreatic Fluid Collections

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • EUS-guided intervention using the RIVOS™ EUS access device — DEVICE
    EUS-guided intervention using the RIVOS™ EUS access device

Study Details

This is a prospective study of patients undergoing EUS procedures using the RIVOS™ EUS access device.

Key Dates

First listed
Jul 10, 2026
Start date
Jul 31, 2026
Status verified
Jul 2026
Primary completion
Jul 31, 2027
Completion
Dec 31, 2027

Study Design

Enrollment
30 participants (estimated)

Arms

  • Arm: Patients requiring interventional EUS procedures
    Patients requiring interventional EUS procedures

Primary Outcome Measure

Technical success [ Time Frame: 1 day ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Orlando Health Digestive Health InstituteOrlandoFlorida32806
Ji Young Bang, MD MPH
[email protected]
321-842-2273
Barbara J Broome
[email protected]
Ji Young Bang, MD MPH (PRINCIPAL_INVESTIGATOR)

Find similar trials in Orlando, FL

By research site
Orlando Health Digestive Health Institute· Orlando, FL

Related Studies